Figure 6
Figure 6. The expression of Tyk2 in DCs is required for the optimal Th1-cell differentiation. (A) Splenic CD4+ T cells (1 × 106 cells) from DO11.10+ mice were stimulated with OVA323–339 peptide (0.2 μg/mL) in the presence of WT or Tyk2−/− CD11c+ DCs (2 × 105 cells). Where indicated, IL-12 (10 ng/mL) or anti–IFN-γ antibody (15 μg/mL) was added to the culture. Five days later, intracellular staining for IL-4 and IFN-γ was performed and analyzed by FACS. Representative FACS profiles of IL-4 versus IFN-γ gated on CD4+ CD11c− cells are shown from 5 independent experiments. (B) DO11.10+ CD4+ T cells were stimulated with OVA323–339 peptide in the presence of WT or Tyk2−/− CD11c+ DCs with or without IL-12 (10 ng/mL). Five days later, the levels of IFN-γ, IL-4, and IL-5 in the culture supernatants were determined by ELISA. Data are means (± SD) from 5 independent experiments. *Significantly different from the corresponding mean values of WT DCs, *P < .05. (C) DO11.10+ CD4+ T cells (2 × 105 cells) were stimulated with OVA323–339 peptide in the presence of WT or Tyk2−/− CD11c+ DCs (4 × 104 cells) with or without IL-12 in a 96-well microtiter plate for 72 hours, with 1 μCi (0.037 MBq) [3H] thymidine added for the final 12 hours. Data are means (± SD) of [3H] thymidine uptake from 4 independent experiments. (D) DO11.10+ CD4+ T cells were stimulated with OVA323–339 peptide in the presence of WT or Tyk2−/− CD11c+ DCs. Where indicated, IL-12 or anti–IFN-γ antibody was added to the culture. Five days later, the levels of IL-17 in the culture supernatants were determined by ELISA. Data are means (± SD) from 5 independent experiments. *P < .05.

The expression of Tyk2 in DCs is required for the optimal Th1-cell differentiation. (A) Splenic CD4+ T cells (1 × 106 cells) from DO11.10+ mice were stimulated with OVA323–339 peptide (0.2 μg/mL) in the presence of WT or Tyk2−/− CD11c+ DCs (2 × 105 cells). Where indicated, IL-12 (10 ng/mL) or anti–IFN-γ antibody (15 μg/mL) was added to the culture. Five days later, intracellular staining for IL-4 and IFN-γ was performed and analyzed by FACS. Representative FACS profiles of IL-4 versus IFN-γ gated on CD4+ CD11c cells are shown from 5 independent experiments. (B) DO11.10+ CD4+ T cells were stimulated with OVA323–339 peptide in the presence of WT or Tyk2−/− CD11c+ DCs with or without IL-12 (10 ng/mL). Five days later, the levels of IFN-γ, IL-4, and IL-5 in the culture supernatants were determined by ELISA. Data are means (± SD) from 5 independent experiments. *Significantly different from the corresponding mean values of WT DCs, *P < .05. (C) DO11.10+ CD4+ T cells (2 × 105 cells) were stimulated with OVA323–339 peptide in the presence of WT or Tyk2−/− CD11c+ DCs (4 × 104 cells) with or without IL-12 in a 96-well microtiter plate for 72 hours, with 1 μCi (0.037 MBq) [3H] thymidine added for the final 12 hours. Data are means (± SD) of [3H] thymidine uptake from 4 independent experiments. (D) DO11.10+ CD4+ T cells were stimulated with OVA323–339 peptide in the presence of WT or Tyk2−/− CD11c+ DCs. Where indicated, IL-12 or anti–IFN-γ antibody was added to the culture. Five days later, the levels of IL-17 in the culture supernatants were determined by ELISA. Data are means (± SD) from 5 independent experiments. *P < .05.

Close Modal

or Create an Account

Close Modal
Close Modal